Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 58.01
+2.19 (3.92%)
Sep 30, 2026, 4:00 PM EDT
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 26.98 billion as of October 7, 2026. That makes SHA:688192 the world's 4,294th most valuable company and 651st in China. Its market cap has decreased by 17.30% in one year.
Market Cap
26.98B
Enterprise Value
26.60B
Revenue
968.83M
Global Rank
Country Rank
#651 China
PE Ratio
n/a
ChartMarket Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 26.98B, an increase of 64.14%. That is a compound annual growth rate of 10.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 26.98B | 1.58% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Humanwell Healthcare (Group) | 31.29B |
| Apeloa Pharmaceutical Co.,Ltd | 31.23B |
| Dong-E-E-Jiao | 29.33B |
| Changchun High-Tech Industry (Group) | 28.86B |
| Shijiazhuang Yiling Pharmaceutical | 25.65B |
| Livzon Pharmaceutical Group | 25.17B |
| Zhejiang Huahai Pharmaceutical | 24.35B |
| Hubei Jumpcan Pharmaceutical | 23.62B |